| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 2.732 | 467.566 | 223.591 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 2.732 | 469.862 | 223.643 |
| Total Expenses - EUR | - | - | - | - | - | 78 | 1.789 | 2.302 | 386.525 | 211.567 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -78 | -1.789 | 429 | 83.337 | 12.076 |
| Net Profit/Loss - EUR | - | - | - | - | - | -78 | -1.789 | 402 | 78.634 | 9.936 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bioroyal S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 114 | 0 | 48 | 48 | 0 |
| Current Assets | - | - | - | - | - | 2.069 | 364 | 2.944 | 85.466 | 15.986 |
| Inventories | - | - | - | - | - | 0 | 0 | 2.344 | 59.913 | 12.885 |
| Receivables | - | - | - | - | - | 2 | 245 | 356 | 4.505 | 1.695 |
| Cash | - | - | - | - | - | 2.067 | 119 | 244 | 21.048 | 1.406 |
| Shareholders Funds | - | - | - | - | - | 1.989 | 156 | 559 | 79.191 | 12.349 |
| Social Capital | - | - | - | - | - | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | - | - | - | - | - | 194 | 207 | 2.434 | 6.323 | 3.637 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Bioroyal S.r.l.